SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

September 26, 2011 08:35 ET

MMRGlobal Projects Third Quarter MMRPro Installs to Generate Patient Revenues of More Than $5 Million

LOS ANGELES, CA--(Marketwire - Sep 26, 2011) - MMRGlobal, Inc. (OTCBB: MMRF) (, a leading provider of Personal Health Records, MyEsafeDepositBox storage solutions and electronic document management systems for healthcare professionals, today announced that revenue from 30 MMRPro systems installed or in the process of being installed during the third quarter are projected to generate sales and deferred revenue of more than $600,000 plus patient revenue from ( of an additional $5 million over the first 12 months following completion of the current quarter's installations. The projections are based on the deployment of each MMRPro system in facilities supporting an average of five healthcare professionals for five days per week generating an average of 1.5 upgrades per physician per day. This patient upgrade revenue does not include residual income from subsequent year renewals. The Company's patient attrition rates on its residual renewals have been under five percent per year.

The Company also launched a new MMRPro video featuring spokesperson Kira Reed which can be seen at

Robert H. Lorsch, Chairman and CEO of MMRGlobal said, "There have been a significant number of articles in the media over the past month weighing in on the effectiveness, value and importance of Personal Health Records. We believe this could be the long awaited beginning of patient awareness and the boom in health IT. Our PHR is the only consumer-centric Personal Health Record that covers an individual's entire family including pets at no additional cost and connects to any Electronic Medical Record or regional health system presently in use anywhere in the world. We can deliver our products and services globally both via the Internet and an ordinary dial tone."

On September 12th, Department of Health and Human Services (HHS) Secretary Kathleen Sebelius urged healthcare professionals to make Personal Health Records available to all patients and asked the medical profession to "take the pledge" to cooperate in expanding the rights of patients to access their personal health information.

Recent studies have shown that, overall, healthcare spending is projected to reach $4.5 trillion in 2019, consuming 19.3 percent of the GDP. It has been estimated that $82 billion to $100 billion in savings could be immediately realized in coordination of care using computerized health records. The rising demand for healthcare cost containment and the need to improve the quality of healthcare in the U.S. are driving the EMR market in the U.S., which is expected to grow to over $6 billion by 2015 at an estimated compound annual growth rate (CAGR) of 18.1 percent between 2010 and 2015.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR") (, provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. MyMedicalRecords enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. The MyMedicalRecords Personal Health Record is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for healthcare professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit

Forward-Looking Statements

All statements in this press release that are not strictly historical in nature, including future performance, management's expectations, beliefs, intentions, estimates or projections, constitute "forward-looking statements." Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the Company's actual results to be materially different from historical results or from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and "continue," or the negative of these words. Factors that could cause or contribute to such differences include, but are not limited to, the risk the Company's products are not adopted or viewed favorably by the healthcare community; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; financial projections; product integration in physician practices, surgery centers and hospitals; timing and volume of sales and installations of MMRPro and revenue from; length of sales cycles and the installation process; market acceptance of new product introductions; ability to establish and maintain strategic relationships; ability to identify and integrate acquisitions; relationships with licensees; competitive product offerings and promotions; changes in government laws and regulations, especially as related to the healthcare industry; future changes in tax legislation and initiatives and exposure to additional tax liabilities; undetected errors in our products; possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; current and future litigation; acceptance of the Company's marketing and promotional campaigns; the value of the Company's broadcasting advertising and sponsorships; negotiated milestone payments; risks related to a security breach by third parties; maintaining, developing and defending our intellectual property rights including those pertaining to our biotechnology assets; risks associated with recruitment and retention of key personnel; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in the Company's filings with the Securities and Exchange Commission. Additionally, we are a developing early-stage company and many variables can affect revenues and/or projections, including factors out of our control. The Company is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise. You are cautioned not to place undue reliance on the forward-looking statements set forth in this press release.

Contact Information